• Study on Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain
  • Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

    Not recruiting

    4 1 1
    Investigated Diseases:
    Austria Czechia Denmark Estonia Finland France +9
  • Study of SLN124 for Patients with Polycythemia Vera

    Not recruiting

    1 1
    Investigated Diseases:
    Bulgaria Germany Italy Poland Spain
  • Study on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Dystrophy After Cataract Surgery

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Germany Spain
  • Study on the Safety and Effects of Crovalimab for Treating Vaso-Occlusive Episodes in Sickle Cell Disease Patients

    Not recruiting

    1 1
    Investigated Drugs:
    France Italy The Netherlands Spain
  • Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

    Not recruiting

    3 1 1
    Belgium Czechia France Germany Italy The Netherlands +3
  • Study on BJT-778 for Patients with Chronic Hepatitis B and D Infections

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Romania
  • Study on the Effect of Patiromer on Vascular Health in Patients with Chronic Kidney Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Estonia Finland Slovakia Spain Sweden

powered by